35 results on '"Aktas, Mehmet"'
Search Results
2. Use of oral contraceptives in women with congenital long QT syndrome
3. Cardiac resynchronization therapy and ventricular tachyarrhythmia burden
4. Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring
5. Predictors and outcomes of atrial tachyarrhythmia among patients with implantable defibrillators
6. PO-03-216 HYBRID VT ABLATION-SUBCUTANEOUS ICD MANAGEMENT STRATEGY FOR SECONDARY PREVENTION OF SUDDEN CARDIAC DEATH: THE VTABL-SICD TRIAL
7. PO-04-226 RISK OF VENTRICULAR RECURRENT TACHYARRHYTHMIA IN PATIENTS RECEIVING PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
8. MP-453089-1 DIGOXIN AND RISK OF VENTRICULAR TACHYARRHYTHMIA AND DEATH IN ICD RECIPIENTS
9. Bipolar left ventricular pacing is associated with significant reduction in heart failure or death in CRT-D patients with LBBB
10. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device
11. “QT clock” to improve detection of QT prolongation in long QT syndrome patients
12. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
13. PO-628-03 ASSOCIATION OF MINERALOCORTICOID RECEPTOR ANTAGONIST USE WITH MORTALITY AND VENTRICULAR ARRHYTHMIA RISK IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
14. CI-563-01 SEX DIFFERENCES IN THE ASSOCIATION OF OBESITY AND VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
15. PO-699-07 RISK OF SUDDEN CARDIAC DEATH IN PATIENTS UNDERGOING CANCER TREATMENT
16. HF-567-01 THE BENEFIT OF AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN HEART FAILURE PATIENTS TREATED WITH EMPAGLIFLOZIN: AN ANALYSIS FROM THE EMPEROR-REDUCED TRIAL
17. PO-628-04 THE EFFECT OF METOPROLOL VERSUS CARVEDILOL ON THE RISK OF ATRIAL AND VENTRICULAR ARRHYTHMIA IN PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR RECIPIENTS
18. PO-629-07 TRIGGERED SYNCOPE AND THE RISK FOR SUBSEQUENT LIFE THREATENING EVENTS IN LONG QT SYNDROME
19. PO-654-04 RISK OF NEW ONSET ATRIAL FIBRILLATION ASSOCIATED WITH CONTEMPORARY TREATMENT OF LYMPHOMA
20. PO-06-067 ARRHYTHMIC OUTCOMES ASSOCIATED WITH HISTORY OF NON-SUSTAINED VENTRICULAR TACHYCARDIA IN PRIMARY PREVENTION ICD RECIPIENTS
21. PO-06-049 SEX HORMONES AND REPOLARIZATION DYNAMICS DURING THE MENSTRUAL CYCLE IN WOMEN TREATED WITH QT-PROLONGING DRUGS
22. PO-06-174 CLINICAL IMPLICATIONS OF ATRIAL FIBRILLATION RECURRENCE VS. BURDEN FOLLOWING CATHETER ABLATION IN CONTEMPORARY CLINICAL TRIALS: OUTCOME DATA FROM 3 ONGOING RANDOMIZED CLINICAL TRIALS USING AN INSERTABLE CARDIAC MONITOR
23. PO-02-161 RISK STRATIFICATION FOR A PRIMARY PREVENTION ICD: PERFORMANCE OF THE MADIT-ICD BENEFIT SCORE IN A CONTEMPORARY REAL WORLD COHORT
24. PO-02-100 LATE MENARCHE ONSET AND THE RISK OF CARDIAC EVENTS AFTER THE ONSET OF ADOLESCENCE IN WOMEN WITH LONG QT SYNDROME
25. PO-02-077 A COMPARATIVE STUDY OF KARDIAMOBILE 6L DERIVED RECORDINGS VERSUS CONVENTIONAL HOLTER RECORDINGS IN THE DETECTION OF CARDIAC ARRHYTHMIAS
26. PO-01-120 INTRAOPERATIVE ABLATION OF VENTRICULAR TACHYCARDIA DURING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION GUIDED BY CARDIOINSIGHT NON-INVASIVE MAPPING, A PILOT STUDY
27. B-AB07-05 MYOCARDIAL 18-FLUORODEOXYGLUCOSE UPTAKE IN PATIENTS WITH CARDIAC SARCOIDOSIS AND ATRIAL ARRHYTHMIAS UNDERGOING 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY
28. B-PO03-149 OPTIMAL HEART RATE CORRECTION OF THE QT INTERVAL IN AF PATIENTS
29. B-PO03-072 REDUCTION IN VENTRICULAR TACHYARRHYTHMIA BURDEN IN PATIENTS ENROLLED IN THE RANOLAZINE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (RAID) TRIAL
30. B-PO05-024 BIOLOGICAL LIFE-STAGE, MENARCHE ONSET, AND THE BURDEN OF CARDIAC EVENTS IN WOMEN WITH CONGENITAL LONG QT SYNDROME
31. B-AB11-02 COMPETING RISK OF VENTRICULAR ARRHYTHMIA AND NON-ARRHYTHMIC MORTALITY BY AGE: COMBINED ASSESSMENT FROM LANDMARK ICD TRIALS
32. B-PO04-129 INTRAOPERATIVE VENTRICULAR TACHYCARDIA ABLATION DURING LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IN HIGH-RISK HEART FAILURE PATIENTS
33. Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: A MADIT-CRT substudy
34. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT
35. Risk of recurrent ventricular tachyarrhythmia following the occurrence of a first ventricular arrhythmic event in patients with a primary prevention implantable cardioverter-defibrillator.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.